Maryjo Chamberlain-Tharp

Corporate Officer/Principal at NEUMORA THERAPEUTICS, INC.

50 year

Health Technology

Consumer Services

Finance

Profile

Maryjo Chamberlain-Tharp currently works at ARCH Venture Partners LLC, as Venture Partner from 2025 and Neumora Therapeutics, Inc., as Chief Business Officer from 2022.
Dr. Chamberlain-Tharp also formerly worked at Eli Lilly & Co., as Head-Neuroscience & East Coast Operations from 1997 to 2014 and AbbVie, Inc., as Global Head-Academic Outreach from 2014 to 2021.
Dr. Chamberlain-Tharp received his doctorate degree from Walden University LLC, undergraduate degree from Purdue University, and Masters Business Admin degree from Indiana University Bloomington.

Maryjo Chamberlain-Tharp active positions

Companies	Position	Start
NEUMORA THERAPEUTICS, INC.	Corporate Officer/Principal	2021-07-31
ARCH Venture Partners LLC ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments.	Private Equity Investor	2025-06-30

All active positions of Maryjo Chamberlain-Tharp

Former positions of Maryjo Chamberlain-Tharp

Companies	Position	End
ABBVIE INC.	Corporate Officer/Principal	2021-07-31
ELI LILLY AND COMPANY	Corporate Officer/Principal	2013-12-31

See the detail of Maryjo Chamberlain-Tharp's experience

Training of Maryjo Chamberlain-Tharp

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Maryjo Chamberlain-Tharp's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
Eli Lilly & Co. Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products	Health Technology
ARCH Venture Partners LLC ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments.	Finance
AbbVie, Inc. AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies	Health Technology
Walden University LLC Walden University LLC Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Purdue University Purdue University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Neumora Therapeutics, Inc. Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases	Health Technology
Indiana University Bloomington Indiana University Bloomington Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services